Study of ATH-1017 for the Treatment of Alzheimer's Disease

Clinical Trial Title

Study of ATH-1017 for the Treatment of Alzheimer's Disease

National Clinical Trial Number:


Contact Information

Clinical Trial Protocol Description:

The purpose of the study is to test if an experimental drug called ATH-1017 is safe and helpful to people with memory and thinking problems associated with Alzheimer's Disease. The study treatments, ATH-1017 or a placebo, will be assigned randomly. Nationwide, 300 participants will be recruited for this study. At Rush University Medical Center, we expect to recruit up to 15 participants.

Clinical Trial Eligibility Criteria:

In order to participate, you must:

  • Be 55-85 years old.
  • Have a diagnosis of mild to moderate Alzheimer's Disease.
  • Have an individual who knows you well willing to take part in the study with you as your study partner.

You will be excluded from the study if you:

  • Are unable or unwilling to complete all study activities.
  • Have other medical conditions, illnesses or diseases that could interfere with study participation.

This is a partial list of inclusion and exclusion criteria.

Study Details

Clinical Trial Investigator

Raj C. Shah, MD

Contact Information

Judy Phillips

Clinical Trial Location

RUSH University Medical Center


RUSH University Medical Center

1620 W Harrison St
Chicago, IL 60612

Get Directions

Clinical Trial FAQs

Find out if a clinical trial makes sense for you.

Learn more
Learn more